ChimeriVax™-JE

BIOLOGICAL2 trials

Sponsors

Sanofi

Conditions

Japanese Encephalitis

Phase 2

Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

CompletedNCT00441259

SanofiJapanese Encephalitis

Start: 2007-01-31End: 2011-12-31Updated: 2012-08-27

Phase 3

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

CompletedNCT00314145

SanofiJapanese Encephalitis

Start: 2005-11-30End: 2006-11-30Updated: 2012-12-06